Sensei Biotherapeutics, Inc. (SNSE)
NASDAQ: SNSE · Real-Time Price · USD
0.3450
-0.0490 (-12.44%)
At close: Apr 1, 2025, 4:00 PM
0.3307
-0.0143 (-4.14%)
After-hours: Apr 1, 2025, 7:57 PM EDT

Sensei Biotherapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2015
Net Income
-30.16-34.1-48.59-36.79-20.1
Upgrade
Depreciation & Amortization
1.321.351.350.690.21
Upgrade
Loss (Gain) From Sale of Assets
-0.3-0.02-0.03-
Upgrade
Asset Writedown & Restructuring Costs
0.95----
Upgrade
Loss (Gain) From Sale of Investments
-0.99-1.060.220.62-
Upgrade
Stock-Based Compensation
3.144.455.815.661.49
Upgrade
Other Operating Activities
1.551.361.19-0.511.09
Upgrade
Change in Accounts Payable
-0.45-2.332.02-1.430.34
Upgrade
Change in Other Net Operating Assets
-0.04-2-1.011.54-0.73
Upgrade
Operating Cash Flow
-24.67-32.02-39.03-30.26-17.71
Upgrade
Capital Expenditures
-0.15-0.18-0.32-2.03-1.21
Upgrade
Sale of Property, Plant & Equipment
-0.170.020.32-
Upgrade
Cash Acquisitions
-----0.2
Upgrade
Investment in Securities
22.5938.4350.26-141.41-
Upgrade
Investing Cash Flow
22.4438.4149.95-143.12-1.4
Upgrade
Long-Term Debt Issued
----0.57
Upgrade
Total Debt Issued
----0.57
Upgrade
Long-Term Debt Repaid
-0.81-0.76-0.63-0.26-0.04
Upgrade
Net Debt Issued (Repaid)
-0.81-0.76-0.63-0.260.53
Upgrade
Issuance of Common Stock
0.030.050.34140.70.02
Upgrade
Repurchase of Common Stock
-0.01-10.46---
Upgrade
Other Financing Activities
-----2.11
Upgrade
Financing Cash Flow
-0.79-11.17-0.29163.9435.45
Upgrade
Net Cash Flow
-3.02-4.7810.64-9.4416.35
Upgrade
Free Cash Flow
-24.82-32.2-39.35-32.29-18.91
Upgrade
Free Cash Flow Per Share
-0.99-1.15-1.28-1.17-11.73
Upgrade
Levered Free Cash Flow
-17.84-21.32-22.49-17.56-16.35
Upgrade
Unlevered Free Cash Flow
-17.79-21.23-22.36-17.14-15.29
Upgrade
Change in Net Working Capital
-0.833.75-2.17-1.974.09
Upgrade
Updated Mar 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q